MedCap AB (publ) (FRA:61MA)
Germany · Delayed Price · Currency is EUR 44.40
+0.15 (0.34%)
At close: Feb 20, 2026
MedCap AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 219.8 | 207.4 | 172.2 | 117.6 | 96.5 |
Depreciation & Amortization | 153.3 | 101.5 | 89.5 | 68.9 | 65.1 |
Other Amortization | - | 13.9 | 14.5 | 12.4 | 10.4 |
Loss (Gain) From Sale of Assets | - | -0.5 | -0.3 | -0.3 | -0.1 |
Asset Writedown & Restructuring Costs | - | - | - | 6.5 | - |
Other Operating Activities | -35.2 | -34 | 21.5 | 26.6 | -0.2 |
Change in Accounts Receivable | -47 | 44.1 | -8.3 | -159.8 | -36.5 |
Change in Inventory | 22.4 | 42.3 | -47.2 | -10.8 | -16 |
Change in Other Net Operating Assets | 29.4 | -14.7 | -13.9 | 24.4 | -2.9 |
Operating Cash Flow | 342.7 | 360 | 228 | 85.5 | 116.3 |
Operating Cash Flow Growth | -4.81% | 57.89% | 166.67% | -26.48% | 0.95% |
Capital Expenditures | -25.7 | -41.7 | -22.1 | -26.3 | -45.3 |
Sale of Property, Plant & Equipment | 0.7 | - | - | - | - |
Cash Acquisitions | -330.1 | -62.7 | -113.1 | -11.9 | -4.6 |
Sale (Purchase) of Intangibles | -36.5 | -24.5 | -17.2 | -18 | -15.6 |
Investment in Securities | 0.3 | 2 | 1 | 0.1 | 0.7 |
Other Investing Activities | - | -1.9 | -0.9 | - | - |
Investing Cash Flow | -391.3 | -128.8 | -152.3 | -56.1 | -64.8 |
Short-Term Debt Issued | - | - | - | - | 0.9 |
Long-Term Debt Issued | 181 | - | - | 120 | - |
Total Debt Issued | 181 | - | - | 120 | 0.9 |
Short-Term Debt Repaid | -0.7 | -15 | -36.9 | -2.8 | - |
Long-Term Debt Repaid | -132.1 | -67 | -84.6 | -54.4 | -66 |
Total Debt Repaid | -132.8 | -82 | -121.5 | -57.2 | -66 |
Net Debt Issued (Repaid) | 48.2 | -82 | -121.5 | 62.8 | -65.1 |
Issuance of Common Stock | 30 | 35.9 | 1.8 | 5.7 | 1.1 |
Repurchase of Common Stock | -26.1 | - | - | -7.4 | - |
Other Financing Activities | 0.1 | - | - | 0.1 | -0.1 |
Financing Cash Flow | 52.2 | -46.1 | -119.7 | 61.2 | -64.1 |
Foreign Exchange Rate Adjustments | -3.4 | -3.2 | -4.1 | 5.9 | 5.7 |
Miscellaneous Cash Flow Adjustments | - | - | 0.1 | - | - |
Net Cash Flow | 0.2 | 181.9 | -48 | 96.5 | -6.9 |
Free Cash Flow | 317 | 318.3 | 205.9 | 59.2 | 71 |
Free Cash Flow Growth | -0.41% | 54.59% | 247.80% | -16.62% | -31.66% |
Free Cash Flow Margin | 15.04% | 17.61% | 12.96% | 5.27% | 7.66% |
Free Cash Flow Per Share | 21.13 | 21.47 | 13.86 | 4.00 | 4.80 |
Cash Interest Paid | 6.4 | 6.6 | 8.5 | 3 | 7.7 |
Cash Income Tax Paid | 91.3 | 73.6 | 33.3 | 23.9 | 24.2 |
Levered Free Cash Flow | 299.16 | 214.8 | 206.78 | -14.96 | 21 |
Unlevered Free Cash Flow | 314.66 | 226.36 | 216.53 | -4.71 | 26.88 |
Change in Working Capital | 4.8 | 71.7 | -69.4 | -146.2 | -55.4 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.